Catalyst
Slingshot members are tracking this event:
Merrimack Announces a Leading-edge Biomarker-Selected, Multi-Arm Basket Trial that Matches Patients with Most Appropriate Combination Regimens
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MACK | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 19, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Multi-arm Basket Trial, Biomarker-selected, Appropriate Combination Regimens
